{"id":"https://openalex.org/W4367608802","doi":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3954","title":"Unbiased Identification of Serum Response Factor as a Central Profibrotic Mechanism in Idiopathic Pulmonary Fibrosis","display_name":"Unbiased Identification of Serum Response Factor as a Central Profibrotic Mechanism in Idiopathic Pulmonary Fibrosis","alternate_titles":[],"publication_year":2023,"publication_date":"2023-05-01","ids":{"openalex":"https://openalex.org/W4367608802","doi":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3954"},"language":"en","primary_location":{"id":"doi:10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3954","doi":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3954","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3954","pdf_url":null,"source":{"id":"https://openalex.org/S93356601","display_name":"American Journal of Respiratory and Critical Care Medicine","issn_l":"1073-449X","issn":["1073-449X","1535-4970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316311","host_organization_name":"American Thoracic Society","host_organization_lineage":["https://openalex.org/P4310316311"],"host_organization_lineage_names":["American Thoracic Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"B65. IMMUNE AND ENDOTHELIAL CELLS HIT BACK AT LUNG REPAIR","raw_type":"proceedings-article"},"parent_works":[],"lineage":["https://openalex.org/W4367608802"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052758096","display_name":"Henric Olsson","orcid":"https://orcid.org/0000-0002-5101-8871","observed_orcids":["https://orcid.org/0000-0002-5101-8871"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"H. Olsson","raw_affiliation_strings":["Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038046907","display_name":"Johan Mattsson","orcid":"https://orcid.org/0000-0002-1696-423X","observed_orcids":["https://orcid.org/0000-0002-1696-423X"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"J. Mattsson","raw_affiliation_strings":["Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074187475","display_name":"Catherine L. Overed-Sayer","orcid":"https://orcid.org/0000-0003-0068-0635","observed_orcids":["https://orcid.org/0000-0003-0068-0635"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. Overed-Sayer","raw_affiliation_strings":["COPD & IPF Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"COPD & IPF Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065009371","display_name":"M. Stellato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M. Stellato","raw_affiliation_strings":["COPD & IPF Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"COPD & IPF Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017678937","display_name":"A. McElroy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. McElroy","raw_affiliation_strings":["COPD & IPF Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"COPD & IPF Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124263614","display_name":"Julie Weidner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"J. Weidner","raw_affiliation_strings":["Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039155418","display_name":"Greet De Baets","orcid":"https://orcid.org/0000-0001-8844-800X","observed_orcids":["https://orcid.org/0000-0001-8844-800X"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G. De Baets","raw_affiliation_strings":["Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016498713","display_name":"Susan J. Monkley","orcid":"https://orcid.org/0000-0001-9174-6278","observed_orcids":["https://orcid.org/0000-0001-9174-6278"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"S. Monkley","raw_affiliation_strings":["Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028584928","display_name":"Michael H. H\u00fchn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"M. H\u00fchn","raw_affiliation_strings":["Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053644742","display_name":"Daniel Muthas","orcid":"https://orcid.org/0000-0001-9320-2004","observed_orcids":["https://orcid.org/0000-0001-9320-2004"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"D. Muthas","raw_affiliation_strings":["Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013102519","display_name":"C. Bendtsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"C. Bendtsen","raw_affiliation_strings":["Data Sciences & Quantitative Biology, Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Data Sciences & Quantitative Biology, Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077735093","display_name":"Leire Escudero\u2010Ibarz","orcid":"https://orcid.org/0000-0001-7650-131X","observed_orcids":["https://orcid.org/0000-0001-7650-131X"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L. Escudero-Ibarz","raw_affiliation_strings":["Functional Genomics, Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Functional Genomics, Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031302003","display_name":"A. Serrano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Serrano","raw_affiliation_strings":["Functional Genomics, Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Functional Genomics, Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014414118","display_name":"I. Barrett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"I. Barrett","raw_affiliation_strings":["Data Sciences & Quantitative Biology, Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Data Sciences & Quantitative Biology, Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081439394","display_name":"C. Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. Kim","raw_affiliation_strings":["Data Sciences & Quantitative Biology, Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Data Sciences & Quantitative Biology, Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112603800","display_name":"Mei Ding","orcid":"https://orcid.org/0000-0001-8146-1535","observed_orcids":["https://orcid.org/0000-0001-8146-1535"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"M. Ding","raw_affiliation_strings":["Discovery Biology, Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Johansson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"J. Johansson","raw_affiliation_strings":["R&I, Neuroscience and Microbial Safety, Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&I, Neuroscience and Microbial Safety, Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081742857","display_name":"K. Patten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"K. Patten","raw_affiliation_strings":["R&I, Neuroscience and Microbial Safety, Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&I, Neuroscience and Microbial Safety, Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012420113","display_name":"S. Reichert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122598","display_name":"BenevolentAI (United Kingdom)","ror":"https://ror.org/02z480994","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210122598"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Reichert","raw_affiliation_strings":["Benevolent AI, London,  United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Benevolent AI, London,  United Kingdom","institution_ids":["https://openalex.org/I4210122598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083664189","display_name":"V. Lang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122598","display_name":"BenevolentAI (United Kingdom)","ror":"https://ror.org/02z480994","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210122598"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"V. Lang","raw_affiliation_strings":["Benevolent AI, London,  United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Benevolent AI, London,  United Kingdom","institution_ids":["https://openalex.org/I4210122598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018782098","display_name":"P. Sanders","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122598","display_name":"BenevolentAI (United Kingdom)","ror":"https://ror.org/02z480994","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210122598"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P. Sanders","raw_affiliation_strings":["Benevolent AI, London,  United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Benevolent AI, London,  United Kingdom","institution_ids":["https://openalex.org/I4210122598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082149072","display_name":"M. Catapano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122598","display_name":"BenevolentAI (United Kingdom)","ror":"https://ror.org/02z480994","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210122598"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M. Catapano","raw_affiliation_strings":["Benevolent AI, London,  United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Benevolent AI, London,  United Kingdom","institution_ids":["https://openalex.org/I4210122598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044729811","display_name":"Gabriel Rosser","orcid":"https://orcid.org/0000-0001-9482-573X","observed_orcids":["https://orcid.org/0000-0001-9482-573X"]},"institutions":[{"id":"https://openalex.org/I4210122598","display_name":"BenevolentAI (United Kingdom)","ror":"https://ror.org/02z480994","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210122598"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G. Rosser","raw_affiliation_strings":["Benevolent AI, London,  United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Benevolent AI, London,  United Kingdom","institution_ids":["https://openalex.org/I4210122598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085982484","display_name":"A. Puvanendran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122598","display_name":"BenevolentAI (United Kingdom)","ror":"https://ror.org/02z480994","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210122598"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Puvanendran","raw_affiliation_strings":["Benevolent AI, London,  United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Benevolent AI, London,  United Kingdom","institution_ids":["https://openalex.org/I4210122598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061458752","display_name":"S. McMahon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122598","display_name":"BenevolentAI (United Kingdom)","ror":"https://ror.org/02z480994","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210122598"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. McMahon","raw_affiliation_strings":["Benevolent AI, London,  United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Benevolent AI, London,  United Kingdom","institution_ids":["https://openalex.org/I4210122598"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059689388","display_name":"Chris Tame","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122598","display_name":"BenevolentAI (United Kingdom)","ror":"https://ror.org/02z480994","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210122598"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. Tame","raw_affiliation_strings":["Benevolent AI, London,  United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Benevolent AI, London,  United Kingdom","institution_ids":["https://openalex.org/I4210122598"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A3954","last_page":"A3954"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serum-response-factor","display_name":"serum response factor","score":0.9729999899864197},{"id":"https://openalex.org/keywords/idiopathic-pulmonary-fibrosis","display_name":"idiopathic pulmonary fibrosis","score":0.8199999928474426},{"id":"https://openalex.org/keywords/fibrosis","display_name":"fibrosis","score":0.7160000205039978}],"concepts":[{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.6713663935661316},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.6405761241912842},{"id":"https://openalex.org/C2781244666","wikidata":"https://www.wikidata.org/wiki/Q32446","display_name":"Pulmonary fibrosis","level":3,"score":0.5270940065383911},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46636494994163513},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.401699960231781},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30909258127212524},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23268184065818787},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.06209149956703186},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3954","doi":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3954","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3954","pdf_url":null,"source":{"id":"https://openalex.org/S93356601","display_name":"American Journal of Respiratory and Critical Care Medicine","issn_l":"1073-449X","issn":["1073-449X","1535-4970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316311","host_organization_name":"American Thoracic Society","host_organization_lineage":["https://openalex.org/P4310316311"],"host_organization_lineage_names":["American Thoracic Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"B65. IMMUNE AND ENDOTHELIAL CELLS HIT BACK AT LUNG REPAIR","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2970974876","https://openalex.org/W3041270992","https://openalex.org/W2325966588","https://openalex.org/W3041508060","https://openalex.org/W4396504865","https://openalex.org/W4241100443","https://openalex.org/W4367599861","https://openalex.org/W4225294386","https://openalex.org/W3048887756","https://openalex.org/W648859608"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4367608802","counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2023-05-02T00:00:00"}
